Wolfe Research initiated coverage of AbbVie (ABBV) with an Outperform rating and $205 price target The firm noted that AbbVie sounded ...
News Medical on MSN26m
Prenatal cannabis exposure linked to increased risk of opioid addiction later in lifeWith the increased legalization of recreational cannabis, as many as 1 in 5 pregnant women in the U.S. are now using the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback